Intrinsic Therapeutics Inc.

WOBURN, Massachusetts, September 20, 2011 - Intrinsic Therapeutics, a medical device company focused on developing therapies to address the spine market's many unmet needs, today announced that Cary Hagan has been appointed President and Chief Executive Officer.

WOBURN, Massachusetts, February 17, 2011 - Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid(R) device.